Posted
by Jim Greenwood
on
February 12, 2010 at
1:14pm EST
On February 4th, BIO hosted a media briefing on how efforts to restrict gene patenting and licensing would threaten advances in public health and harm the national economy.
Posted
by Jim Greenwood
on
February 5, 2010 at
9:34am EST
On February 4th, BIO hosted a media briefing on how efforts to restrict gene patenting and licensing would threaten advances in public health and harm the national economy. Participants included:
Posted
by TracyatBIO
on
July 23, 2009 at
5:01am EDT
A recent article in the New York Times fairly captured the essence of the ongoing debate over the appropriate length of the period of data exclusivity to be included in a pathway for biosimilars:
